Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial
- Univ. of Oxford (United Kingdom)
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
- Cardiff Univ., Wales (United Kingdom)
- Bill & Melinda Gates Medical Research Institute, Cambridge, MA (United States); Fred Hutchinson Cancer Research Center, Seattle, WA (United States)
- Fred Hutchinson Cancer Research Center, Seattle, WA (United States)
- Fred Hutchinson Cancer Research Center, Seattle, WA (United States); Univ. of Washington, Seattle, WA (United States)
- Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States)
- Duke Univ., Durham, NC (United States)
Naive and memory CD4+ T cells reactive with human immunodeficiency virus type 1 (HIV-1) are detectable in unexposed, unimmunized individuals. The contribution of preexisting CD4+ T cells to a primary immune response was investigated in 20 HIV-1–seronegative volunteers vaccinated with an HIV-1 envelope (Env) plasmid DNA prime and recombinant modified vaccinia virus Ankara (MVA) boost in the HVTN 106 vaccine trial (clinicaltrials.gov NCT02296541). Prevaccination naive or memory CD4+ T cell responses directed against peptide epitopes in Env were identified in 14 individuals. After priming with DNA, 40% (8/20) of the elicited responses matched epitopes detected in the corresponding preimmunization memory repertoires, and clonotypes were shared before and after vaccination in 2 representative volunteers. In contrast, there were no shared epitope specificities between the preimmunization memory compartment and responses detected after boosting with recombinant MVA expressing a heterologous Env. Preexisting memory CD4+ T cells therefore shape the early immune response to vaccination with a previously unencountered HIV-1 antigen.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE; National Institutes of Health (NIH); Medical Research Council; Wellcome Trust
- Grant/Contract Number:
- 89233218CNA000001
- OSTI ID:
- 1879385
- Report Number(s):
- LA-UR-21-28624
- Journal Information:
- Journal of Clinical Investigation, Journal Name: Journal of Clinical Investigation Journal Issue: 23 Vol. 131; ISSN 0021-9738; ISSN 1558-8238
- Publisher:
- American Society for Clinical InvestigationCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Expanded breadth of the T-cell response to mosaic HIV-1 envelope DNA vaccination